The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air
- PMID: 2247106
- DOI: 10.1056/NEJM199012203232505
The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air
Abstract
Background: The enzyme 5-lipoxygenase catalyzes the metabolism of arachidonic acid to form products that have been implicated in the airway obstruction of asthma. We hypothesized that if products of the 5-lipoxygenase pathway are important in mediating this obstruction, then prevention of their formation should decrease the severity of an induced asthmatic response.
Methods: In a randomized, double-blind, placebo-controlled, crossover study, we examined the effect of A-64077, a 5-lipoxygenase inhibitor, on the bronchoconstriction induced by hyperventilation of cold, dry air in 13 patients with asthma. The completeness of 5-lipoxygenase inhibition was confirmed by examining the profile of eicosanoids produced in whole blood ex vivo after activation with the calcium ionophore A-23187.
Results: A-64077 decreased the mean (+/- SEM) ionophore-induced synthesis of leukotriene B4, a 5-lipoxygenase product, by 74 percent (from 265.3 +/- 30.3 to 69.5 +/- 21.5 ng per milliliter, P less than 0.001), but it did not affect the ionophore-induced synthesis of thromboxane B2, a cyclooxygenase metabolite of arachidonic acid (80.0 +/- 17.1 ng per milliliter before A-64077 vs. 75.8 +/- 14.3 ng per milliliter after A-64077). In concert with the selective inhibition of 5-lipoxygenase by A-64077, the amount of cold, dry air (expressed as respiratory heat exchange) required to reduce the forced expiratory volume in one second by 10 percent was increased by 47 percent after A-64077 (3.0 kJ per minute for placebo vs. 4.4 kJ per minute for A-64077, P less than 0.002). Similar results were obtained when minute ventilation was used as an indicator of outcome (27.5 liters per minute for placebo vs. 39.8 liters per minute for A-64077, P less than 0.005).
Conclusions: Selective inhibition of 5-lipoxygenase by A-64077 is associated with a significant amelioration of the asthmatic response to cold, dry air, suggesting that 5-lipoxygenase products are involved in this response. This approach may be useful in the treatment of asthma.
Comment in
-
Leukotrienes in asthma and allergic rhinitis.N Engl J Med. 1990 Dec 20;323(25):1769-70. doi: 10.1056/NEJM199012203232511. N Engl J Med. 1990. PMID: 2247109 No abstract available.
Similar articles
-
Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air.Thorax. 1997 Dec;52(12):1074-7. doi: 10.1136/thx.52.12.1074. Thorax. 1997. PMID: 9516902 Free PMC article. Clinical Trial.
-
Effect of chronic 5-lipoxygenase inhibition on airway hyperresponsiveness in asthmatic subjects.Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1203-7. doi: 10.1164/ajrccm.152.4.7551371. Am J Respir Crit Care Med. 1995. PMID: 7551371 Clinical Trial.
-
Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor.N Engl J Med. 1990 Dec 20;323(25):1745-8. doi: 10.1056/NEJM199012203232506. N Engl J Med. 1990. PMID: 1701029 Clinical Trial.
-
[5-lipoxygenase inhibitors in asthma therapy].Nihon Rinsho. 1996 Nov;54(11):3040-4. Nihon Rinsho. 1996. PMID: 8950951 Review. Japanese.
-
Treatment of chronic stable asthma with drugs active on the 5-lipoxygenase pathway.Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):319-20. doi: 10.1159/000237013. Int Arch Allergy Immunol. 1995. PMID: 7613158 Review.
Cited by
-
Development and validation of a liquid chromatography-mass spectrometry method for the determination of zileuton in human plasma.Sci Pharm. 2014 Mar 26;82(3):571-83. doi: 10.3797/scipharm.1402-19. Print 2014 Jul-Sep. Sci Pharm. 2014. PMID: 25853069 Free PMC article.
-
[Reflections on antileukotrienes].Aten Primaria. 2002 Apr 15;29(6):356-8. doi: 10.1016/s0212-6567(02)70583-0. Aten Primaria. 2002. PMID: 11996716 Free PMC article. Review. Spanish. No abstract available.
-
Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.Clin Pharmacokinet. 1995;29 Suppl 2:22-33. doi: 10.2165/00003088-199500292-00005. Clin Pharmacokinet. 1995. PMID: 8620668 Clinical Trial.
-
Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.Respir Med. 2011 May;105(5):667-73. doi: 10.1016/j.rmed.2010.11.025. Epub 2010 Dec 18. Respir Med. 2011. PMID: 21169002 Free PMC article. Clinical Trial.
-
Treatment of childhood asthma: how do the available options compare?Paediatr Drugs. 2003;5(10):685-98. doi: 10.2165/00148581-200305100-00004. Paediatr Drugs. 2003. PMID: 14510626 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical